+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Pancreas Device Systems: Global Strategic Business Report

  • PDF Icon

    Report

  • 197 Pages
  • September 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139630

Quick Summary:

Dive into the robust world of the Artificial Pancreas Device Systems Industry. The global artificial pancreas device systems market - valued at US$345.1 million in 2022 - is a rapidly growing sector, braced to reach a staggering US$1.4 billion by the year 2030. This growth is powered by advancements in medical technology and the expanding needs of diabetics for effective and cutting-edge medical solutions.

Our comprehensive market research report is an indispensable tool for business executives looking to gain a competitive edge. It offers in-depth analyses and accurate projections, tracking the performance of key geographic markets including the US, China, Japan, Canada, and Germany. Furthermore, the report has a razor-sharp focus on the trajectories of top competitors such as Beta Bionics, Inc., Bigfoot Biomedical, Inc., Johnson & Johnson, Medtronic PLC, Pancreum, Inc., Tandem Diabetes Care, Inc., and TypeZero Technologies LLC. Additionally, gain critical insights into new developments on the horizon with our special features. Equip your business with the data needed to strategize and stay ahead in this dynamic industry.

Global Artificial Pancreas Device Systems Market to Reach $1.4 Billion by 2030

The global market for Artificial Pancreas Device Systems estimated at US$345.1 Million in the year 2022, is projected to reach a revised size of US$1.4 Billion by 2030, growing at a CAGR of 18.7% over the analysis period 2022-2030. Threshold Suspended Device Systems, one of the segments analyzed in the report, is projected to record 18.8% CAGR and reach US$1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Control-to-Target (CTT) Systems segment is readjusted to a revised 19.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $105 Million, While China is Forecast to Grow at 17.9% CAGR

The Artificial Pancreas Device Systems market in the U.S. is estimated at US$105 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$230.2 Million by the year 2030 trailing a CAGR of 17.9% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.5% and 15.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13.6% CAGR.

Select Competitors (Total 47 Featured) -

  • Beta Bionics, Inc.
  • Bigfoot Biomedical, Inc.
  • Johnson & Johnson
  • Medtronic PLC
  • Pancreum, Inc.
  • Tandem Diabetes Care, Inc.
  • TypeZero Technologies LLC

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Artificial Pancreas Device Systems

What is the estimated value of the Global Market for Artificial Pancreas Device Systems?

The Global Market for Artificial Pancreas Device Systems was estimated to be valued at $345.1 Million in 2022.

What is the growth rate of the Global Market for Artificial Pancreas Device Systems?

The growth rate of the Global Market for Artificial Pancreas Device Systems is 19.1%, with an estimated value of $1400 Million by 2030.

What is the forecasted size of the Global Market for Artificial Pancreas Device Systems?

The Global Market for Artificial Pancreas Device Systems is estimated to be worth $1400 Million by 2030.

Who are the key companies in the Global Market for Artificial Pancreas Device Systems?

Key companies in the Global Market for Artificial Pancreas Device Systems include Beta Bionics, Inc., Bigfoot Biomedical, Inc., Johnson & Johnson, Medtronic PLC, Pancreum, Inc., Tandem Diabetes Care, Inc. and TypeZero Technologies LLC.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Artificial Pancreas Device Systems - Global Key Competitors Percentage Market Share in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World 8-Year Perspective for Artificial Pancreas Device Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
  • Table 3: World Artificial Pancreas Device Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
  • Table 4: World Recent Past, Current & Future Analysis for Threshold Suspended Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World 8-Year Perspective for Threshold Suspended Device Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 6: World Recent Past, Current & Future Analysis for Control-to-Target (CTT) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 7: World 8-Year Perspective for Control-to-Target (CTT) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Control-to-Range (CTR) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 9: World 8-Year Perspective for Control-to-Range (CTR) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 10: USA Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 11: USA 8-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2023 & 2030
CANADA
  • Table 12: Canada Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 13: Canada 8-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2023 & 2030
JAPAN
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 14: Japan Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 15: Japan 8-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2023 & 2030
CHINA
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 16: China Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 17: China 8-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2023 & 2030
EUROPE
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 18: Europe Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 19: Europe 8-Year Perspective for Artificial Pancreas Device Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • Table 20: Europe Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 21: Europe 8-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2023 & 2030
FRANCE
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 22: France Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 23: France 8-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2023 & 2030
GERMANY
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 24: Germany Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 25: Germany 8-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2023 & 2030
ITALY
  • Table 26: Italy Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 27: Italy 8-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2023 & 2030
UNITED KINGDOM
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 28: UK Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 29: UK 8-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2023 & 2030
REST OF EUROPE
  • Table 30: Rest of Europe Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 31: Rest of Europe 8-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2023 & 2030
ASIA-PACIFIC
  • Artificial Pancreas Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 32: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 33: Asia-Pacific 8-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2023 & 2030
REST OF WORLD
  • Table 34: Rest of World Recent Past, Current & Future Analysis for Artificial Pancreas Device Systems by Device - Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
  • Table 35: Rest of World 8-Year Perspective for Artificial Pancreas Device Systems by Device - Percentage Breakdown of Value Sales for Threshold Suspended Device Systems, Control-to-Target (CTT) Systems and Control-to-Range (CTR) Systems for the Years 2023 & 2030
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Beta Bionics, Inc.
  • Bigfoot Biomedical, Inc.
  • Johnson & Johnson
  • Medtronic PLC
  • Pancreum, Inc.
  • Tandem Diabetes Care, Inc.
  • TypeZero Technologies LLC